Company Filing History:
Years Active: 2010-2018
Title: Inventor Spotlight: Andrew Alan Shaw
Introduction
Andrew Alan Shaw is a notable inventor based in Morgantown, West Virginia, who has made significant contributions to the field of pharmaceutical formulations. With a total of four patents to his name, Shaw's innovations have demonstrated a commitment to enhancing drug delivery methods.
Latest Patents
One of Shaw's latest patents involves a novel fenofibrate formulation. These various dosage forms contain a multitude of beads or particles, each comprising a pharmaceutical composition that includes fenofibrate, a surfactant (ranging from 0.3% to 10% by weight), and a water-soluble or water-dispersible cellulosic binder (from about 5% to about 15% by weight). The innovative dosage form achieves a mass ratio of the drug to the binder between approximately 3.5:1 and 4.5:1, resulting in a first Cmax in vivo that is between 10% and 50% higher than that produced by comparative dosage forms, where the drug and binder ratio is between 5:1 and 15:1. This enhancement signifies a substantial advancement in the efficiency of fenofibrate delivery.
Career Highlights
Throughout his career, Andrew Alan Shaw has worked with several renowned companies, including Mylan GmbH and Forest Laboratories Holdings Limited. His experience in these organizations has provided him with a platform to develop and patent his innovative ideas, particularly focusing on drug formulations and their applications.
Collaborations
Shaw has collaborated with esteemed colleagues such as Sarat C. Chattaraj and Glenn Allen Redelman. Their collective efforts have likely contributed to the development and enhancement of pharmaceutical technologies, showcasing the importance of teamwork in the innovation process.
Conclusion
Andrew Alan Shaw exemplifies the spirit of innovation within the pharmaceutical industry through his groundbreaking developments in fenofibrate formulations. With multiple patents that reflect his inventive contributions, Shaw continues to impact drug delivery methods significantly, paving the way for future advancements in pharmaceutical technologies.